Protagenic Therapeutics, Inc.\new (PTIX) Total assets 2017–2026
Protagenic Therapeutics, Inc.\new (PTIX) total assets at each fiscal year-end, per SEC filings.
$3.7MFY2026 · since FY2017: $3.2M → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.7M | +3997.3% |
| FY2025 | $89,093 | -97.9% |
| FY2024 | $4.3M | -46.2% |
| FY2023 | $8.0M | -27.3% |
| FY2022 | $11.1M | +1157.9% |
| FY2021 | $879,247 | — |
| FY2017 | $3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTIX financial trends
PTIX RevenuePTIX Net incomePTIX Net marginPTIX Gross profitPTIX Gross marginPTIX Operating incomePTIX Operating marginPTIX Operating cash flowPTIX Free cash flowPTIX Capital expendituresPTIX Return on equityPTIX Stock buybacksPTIX Dividends paidPTIX Total liabilitiesPTIX Shareholders’ equityPTIX overview →